142 related articles for article (PubMed ID: 35425707)
1. Interim Analysis of Impact of Adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 Pneumonia Patients: IMpaCt-RT Study.
Singh P; Mandal A; Singh D; Kumar S; Kumar A; Rakesh A; Ranjan R; Verma M; Rai DK; Bhushan D; Shankar A; Sinha A; Saini R; Saha A; Thovarayi A; Baral AK; Chauhan S; Kumar R; Kakoty P; Modak B; Ranjan A
Front Oncol; 2022; 12():822902. PubMed ID: 35425707
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa.
Saleh M; Sharma K; Shah J; Karsan F; Waweru A; Musumbi M; Shah R; Sayed S; Abayo I; Karimi N; Gondi S; Rupani S; Kirathe G; Amariati H
PLoS One; 2022; 17(7):e0270594. PubMed ID: 35776736
[TBL] [Abstract][Full Text] [Related]
4. Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India.
Ganesan G; Ponniah S; Sundaram V; Marimuthu PK; Pitchaikannu V; Chandrasekaran M; Thangarasu J; Kannupaiyan G; Ramamoorthy P; Thangaraj B; Shree Vaishnavi R
Radiother Oncol; 2021 Oct; 163():83-90. PubMed ID: 34391759
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
6. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
7. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
[TBL] [Abstract][Full Text] [Related]
8. Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial).
Ganesan G; Ponniah S; Sundaram V; Marimuthu PK; Pitchaikannu V; Chandrasekaran M; Thangarasu J; Kannupaiyan G; Ramamoorthy P; Thangaraj B; Govindaraj HS; Raguram SV
Radiother Oncol; 2022 Feb; 167():133-142. PubMed ID: 34958809
[TBL] [Abstract][Full Text] [Related]
9. Low-dose radiation therapy for COVID-19 pneumonia: a pilot study.
Sharma DN; Guleria R; Wig N; Mohan A; Rath G; Subramani V; Bhatnagar S; Mallick S; Sharma A; Patil P; Madan K; Soneja M; Thulkar S; Singh A; Singh S
Br J Radiol; 2021 Oct; 94(1126):20210187. PubMed ID: 34545760
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
11. Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).
Arenas M; Algara M; De Febrer G; Rubio C; Sanz X; de la Casa MA; Vasco C; Marín J; Fernández-Letón P; Villar J; Torres-Royo L; Villares P; Membrive I; Acosta J; López-Cano M; Araguas P; Quera J; Rodríguez-Tomás F; Montero A
Strahlenther Onkol; 2021 Nov; 197(11):1010-1020. PubMed ID: 34230996
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
13. Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R; Curran WJ; Khan MK
Cancer; 2020 Dec; 126(23):5109-5113. PubMed ID: 32986274
[TBL] [Abstract][Full Text] [Related]
14. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Radiotherapy for Patients with Pneumonia Due to COVID-19: A Single-Institution Prospective Study.
Rutkowski TW; Jaroszewicz J; Piotrowski D; Ślosarek K; Sobala-Szczygieł B; Słonina D; Włostowska B; Bodusz D; Piasecki M; Nachlik M; Oczko-Grzesik B; Gądek A; Kowal D; Rutkowski R; Wojarska-Tręda E; Składowski K
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979837
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of low-dose lung radiotherapy in the management of COVID-19 patients: a randomised, open-label study.
Dinakar K; Jakka MK; Vemannagari PKR; Mohan A; Subramanian BV; Bodagala VD; Bhuma V; Das P; Bonala SR; Vutukuru VR
Br J Radiol; 2023 Dec; 96(1152):20230022. PubMed ID: 37751170
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study.
Papachristofilou A; Finazzi T; Blum A; Zehnder T; Zellweger N; Lustenberger J; Bauer T; Dott C; Avcu Y; Kohler G; Zimmermann F; Pargger H; Siegemund M
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1274-1282. PubMed ID: 33677049
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile of hospitalised moderate category COVID-19 patients: Short study from a Tertiary Care Centre in Delhi.
Gautam S; Kumar R; Bhadoria DP; Mawari G; Kumar N; Daga MK; Pandit S; Anuradha S; Pradhan GS; Garg S; Sharma G; Raghu RV; Ritchie N; Jayamsulekha D
J Family Med Prim Care; 2023 Aug; 12(8):1644-1653. PubMed ID: 37767420
[TBL] [Abstract][Full Text] [Related]
19. Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study.
Papachristofilou A; Finazzi T; Blum A; Zehnder T; Zellweger N; Lustenberger J; Bauer T; Dott C; Avcu Y; Kohler G; Zimmermann F; Pargger H; Siegemund M
Int J Radiat Oncol Biol Phys; 2021 May; ():. PubMed ID: 33957219
[TBL] [Abstract][Full Text] [Related]
20. Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I-II trial.
Sanmamed N; Alcantara P; Gómez S; Bustos A; Cerezo E; Gaztañaga M; Doval A; Corona J; Rodriguez G; Cabello N; Duffort M; Ortuño F; de Castro J; López A; Fuentes M; Sanz A; Vazquez M
Radiother Oncol; 2022 Jun; 171():25-29. PubMed ID: 35367528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
